Mylan’s

Biocon, Mylan’s Biosimilar Trastuzumab gets ANVISA’s approval

Mumbai, Janaury 04, 2018: Biotechnology mAJOR, Biocon and Mylan have received approval for Biosimilar Trastuzumab from ANVISA, the Brazilian regulatory agency,…

7 years ago